Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

1,309

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

November 30, 2000

Conditions
Osteoarthritis
Interventions
DRUG

Meloxicam

DRUG

NSAID

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY